C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCCC | ATYR | VNDA | ||
| Company | C4 Therapeutics Inc | Atyr Pharma Inc | Vanda Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.78 | 3.15 | 4.59 | ||
| High | 3.98 | 3.35 | 4.83 | ||
| Low | 3.72 | 3.13 | 4.59 | ||
| Last | 3.95 | 3.35 | 4.78 | ||
| Change | +0.11 | +0.20 | +0.15 | ||
| % Change | +2.73% | +6.35% | +3.24% | ||
| Volume | 4,578,500 | 1,627,000 | 926,400 | ||
| 20-Day Average Volume | 1,886,555 | 832,045 | 704,175 | ||
| Previous Close | 3.85 | 3.15 | 4.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.21 | 3.25 | 4.83 | ||
| 20-Day Raw Stochastic | 22.82% | 48.19% | 34.02% | ||
| 20-Day Relative Strength | 41.75% | 56.81% | 48.65% | ||
| Weighted Alpha | -30.58 | +95.28 | +9.68 | ||
| Today's Opinion | 100% Sell | 96% Buy | 100% Sell | ||
| Previous Opinion | 100% Sell | 80% Buy | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.82% since 12/13/24 | +9.48% since 12/13/24 | +3.69% since 12/13/24 | ||
| Low | 3.61 on 12/18/24 | 3.02 on 12/16/24 | 4.49 on 12/18/24 | ||
| High | 4.53 on 12/16/24 | 3.35 on 12/20/24 | 4.83 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | -2.47% since 11/20/24 | +12.04% since 11/20/24 | -2.45% since 11/20/24 | ||
| Low | 3.61 on 12/18/24 | 2.88 on 11/21/24 | 4.45 on 12/11/24 | ||
| High | 5.10 on 12/09/24 | 3.78 on 12/09/24 | 5.42 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | -37.80% since 09/20/24 | +84.07% since 09/20/24 | +3.69% since 09/20/24 | ||
| Low | 3.61 on 12/18/24 | 1.67 on 10/01/24 | 4.35 on 10/10/24 | ||
| High | 7.14 on 10/16/24 | 3.80 on 11/13/24 | 5.55 on 11/12/24 | ||
| 6-Month | |||||
| %Chg | -2.47% since 06/20/24 | +112.03% since 06/20/24 | -20.00% since 06/20/24 | ||
| Low | 3.61 on 12/18/24 | 1.42 on 06/21/24 | 4.35 on 10/10/24 | ||
| High | 7.66 on 07/16/24 | 3.80 on 11/13/24 | 6.36 on 07/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 278,827 | 281,206 | 278,712 | ||
| Shares Outstanding, K | 70,589 | 83,942 | 58,308 | ||
| Annual Sales | 20,760,000 | 350,000 | 192,640,000 | ||
| Annual Net Income | -132,490,000 | -50,390,000 | 2,510,000 | ||
| Last Quarter Sales | 15,360,000 | 0 | 47,650,000 | ||
| Last Quarter Net Income | -24,670,000 | -16,310,000 | -5,320,000 | ||
| 60-Month Beta | 2.93 | 1.07 | 0.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 10/31/24 | -0.23 on 11/07/24 | -0.09 on 11/06/24 | ||
| Latest Earnings Date | 11/06/24 | 11/14/24 | 02/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||